ranolazine has been researched along with glycogen in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Clarke, B; McCormack, JG; Patmore, L; Spedding, M | 1 |
| Aaker, A; Hirai, T; McCormack, JG; Musch, TI | 1 |
| Archer, SL; Bache-Wiig, P; Fang, YH; Hong, Z; Marsboom, G; Piao, L; Rehman, J; Toth, PT | 1 |
3 other study(ies) available for ranolazine and glycogen
| Article | Year |
|---|---|
Protective effects of ranolazine in guinea-pig hearts during low-flow ischaemia and their association with increases in active pyruvate dehydrogenase.
Topics: Acetanilides; Adenosine Triphosphate; Angina Pectoris; Animals; Creatine Kinase; Female; Glycogen; Guinea Pigs; Heart; In Vitro Techniques; L-Lactate Dehydrogenase; Lactates; Lactic Acid; Myocardial Ischemia; Myocardium; Perfusion; Phosphocreatine; Piperazines; Pyruvate Dehydrogenase Complex; Ranolazine | 1993 |
Effects of ranolazine on the exercise capacity of rats with chronic heart failure induced by myocardial infarction.
Topics: Acetanilides; Animals; Blood Glucose; Cardiac Output, Low; Enzyme Inhibitors; Female; Glycogen; Lactic Acid; Muscle, Skeletal; Myocardial Infarction; Physical Exertion; Piperazines; Ranolazine; Rats; Rats, Wistar | 1996 |
Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle's cycle.
Topics: Acetanilides; Animals; Enzyme Inhibitors; Fatty Acids; Glucose Transporter Type 1; Glycogen; Glycolysis; Hexokinase; Hypertrophy, Right Ventricular; Male; Myocytes, Cardiac; Oxidation-Reduction; Piperazines; Ranolazine; Rats; Rats, Sprague-Dawley; Trimetazidine; Vasodilator Agents; Ventricular Function, Right | 2012 |